Publications Office of the EU
C/ BASED ON CPA 2024_900 - LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

C/ BASED ON CPA 2024_900 - LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP

  • Awarded
    17/08/2026
  • Today
    09/09/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Unidade Local de Saúde de Coimbra, EPE
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
1,167,804.10 EUR
Tender reference number
050103302026
Description

Purchase of the medicine LAMIVUDINA 300 MG + DOLUTEGRAVIR 50 MG COMP

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Place of performance
Award method
Criterion:
Type: price
Description: Melhor Preço
Weight (percentage, exact): 100
Estimated value
Not available
Final contracted value
1,167,804.10 EUR
Award of contract
Official name: VIIVHIV HEALTHCARE, UNIPESSOAL, LDA
Postal address:
Town: Algés
Postal code: 1499-013
Country:
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.